{"description":"Treatment-Emergent Adverse Events (TEAEs) are defined as any adverse event (all grades) that occurs after administration of the first dose of study drug and through 30 days after the last dose of study drug (Safety Population).The median treatment duration of the safety population for ripretinib arm was 23.86 weeks and placebo was 6 weeks during the double-blind period.","eventGroups":[{"deathsNumAffected":26,"deathsNumAtRisk":85,"description":"Ripretinib (150 mg) once daily in 28-day cycles until disease progression by Independent Radiologic Review (IRR) in patients with advanced gastrointestinal stromal tumors (GIST) who have received treatment with prior therapies (therapies must include treatment with imatinib, sunitinib, and regorafenib).","id":"EG000","otherNumAffected":84,"otherNumAtRisk":85,"seriousNumAffected":26,"seriousNumAtRisk":85,"title":"Ripretinib"},{"deathsNumAffected":26,"deathsNumAtRisk":43,"description":"Placebo once daily in 28-day cycles until disease progression by Independent Radiologic Review (IRR) in patients with advanced gastrointestinal stromal tumors (GIST) who have received treatment with prior therapies (therapies must include treatment with imatinib, sunitinib, and regorafenib).","id":"EG001","otherNumAffected":42,"otherNumAtRisk":43,"seriousNumAffected":19,"seriousNumAtRisk":43,"title":"Placebo"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":85},{"groupId":"EG001","numAffected":8,"numAtRisk":43}],"term":"Anemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":33,"numAtRisk":85},{"groupId":"EG001","numAffected":5,"numAtRisk":43}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":31,"numAtRisk":85},{"groupId":"EG001","numAffected":13,"numAtRisk":43}],"term":"Abdominal Pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":29,"numAtRisk":85},{"groupId":"EG001","numAffected":8,"numAtRisk":43}],"term":"Constipation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":24,"numAtRisk":85},{"groupId":"EG001","numAffected":6,"numAtRisk":43}],"term":"Diarrhea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":18,"numAtRisk":85},{"groupId":"EG001","numAffected":3,"numAtRisk":43}],"term":"Vomiting"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Stomatitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":85},{"groupId":"EG001","numAffected":2,"numAtRisk":43}],"term":"Abdominal Pain (Upper)"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":85},{"groupId":"EG001","numAffected":6,"numAtRisk":43}],"term":"Dyspepsia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":36,"numAtRisk":85},{"groupId":"EG001","numAffected":10,"numAtRisk":43}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":14,"numAtRisk":85},{"groupId":"EG001","numAffected":3,"numAtRisk":43}],"term":"Peripheral Edema"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":85},{"groupId":"EG001","numAffected":6,"numAtRisk":43}],"term":"Asthenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":85},{"groupId":"EG001","numAffected":2,"numAtRisk":43}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":16,"numAtRisk":85},{"groupId":"EG001","numAffected":5,"numAtRisk":43}],"term":"Weight Decreased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":14,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Blood Bilirubin Increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Lipase Increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":85},{"groupId":"EG001","numAffected":2,"numAtRisk":43}],"term":"Aspartate Aminotransferase Increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":85},{"groupId":"EG001","numAffected":1,"numAtRisk":43}],"term":"Blood Alkaline Phosphatase Increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":85},{"groupId":"EG001","numAffected":1,"numAtRisk":43}],"term":"Alanine Aminotransferase Increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":23,"numAtRisk":85},{"groupId":"EG001","numAffected":9,"numAtRisk":43}],"term":"Decreased Appetite"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Hypophosphatemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":85},{"groupId":"EG001","numAffected":1,"numAtRisk":43}],"term":"Hypokalemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":27,"numAtRisk":85},{"groupId":"EG001","numAffected":5,"numAtRisk":43}],"term":"Myalgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":15,"numAtRisk":85},{"groupId":"EG001","numAffected":2,"numAtRisk":43}],"term":"Arthralgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":13,"numAtRisk":85},{"groupId":"EG001","numAffected":2,"numAtRisk":43}],"term":"Muscle Spasms"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":85},{"groupId":"EG001","numAffected":2,"numAtRisk":43}],"term":"Back Pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":85},{"groupId":"EG001","numAffected":2,"numAtRisk":43}],"term":"Pain in Extremity"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":85},{"groupId":"EG001","numAffected":3,"numAtRisk":43}],"term":"Musculoskeletal pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":16,"numAtRisk":85},{"groupId":"EG001","numAffected":2,"numAtRisk":43}],"term":"Headache"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":85},{"groupId":"EG001","numAffected":3,"numAtRisk":43}],"term":"Dizziness"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":85},{"groupId":"EG001","numAffected":1,"numAtRisk":43}],"term":"Peripheral Sensory Neuropathy"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":85},{"groupId":"EG001","numAffected":6,"numAtRisk":43}],"term":"Insomnia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":85},{"groupId":"EG001","numAffected":4,"numAtRisk":43}],"term":"Anxiety"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Depression"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Dyspnea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":85},{"groupId":"EG001","numAffected":1,"numAtRisk":43}],"term":"Cough"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":44,"numAtRisk":85},{"groupId":"EG001","numAffected":2,"numAtRisk":43}],"term":"Alopecia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":18,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Palmar-Plantar Erythrodysesthesia Syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":85},{"groupId":"EG001","numAffected":3,"numAtRisk":43}],"term":"Dry Skin"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":85},{"groupId":"EG001","numAffected":2,"numAtRisk":43}],"term":"Pruritus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":85},{"groupId":"EG001","numAffected":1,"numAtRisk":43}],"term":"Actinic keratosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Dermatitis Acneiform"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Hyperkeratosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":85},{"groupId":"EG001","numAffected":1,"numAtRisk":43}],"term":"Pruritus Generalized"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Rash Maculo-Papular"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":85},{"groupId":"EG001","numAffected":2,"numAtRisk":43}],"term":"Hypertension"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":85},{"groupId":"EG001","numAffected":1,"numAtRisk":43}],"term":"Anemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":85},{"groupId":"EG001","numAffected":2,"numAtRisk":43}],"term":"Abdominal Pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Vomiting"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":85},{"groupId":"EG001","numAffected":4,"numAtRisk":43}],"term":"Death"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Cardiac Failure"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Pericardial Effusion"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":85},{"groupId":"EG001","numAffected":1,"numAtRisk":43}],"term":"Ascites"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Constipation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Duodenal Ulcer"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Fecaloma"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":85},{"groupId":"EG001","numAffected":1,"numAtRisk":43}],"term":"Gastrointestinal Fistula"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Gastroesophageal Reflux Disease"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":85},{"groupId":"EG001","numAffected":1,"numAtRisk":43}],"term":"Small Intestinal Obstruction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Upper Gastrointestinal Hemorrhage"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":85},{"groupId":"EG001","numAffected":1,"numAtRisk":43}],"term":"Gastrointestinal Perforation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"General Physical Health Deterioration"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":85},{"groupId":"EG001","numAffected":2,"numAtRisk":43}],"term":"Asthenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":85},{"groupId":"EG001","numAffected":1,"numAtRisk":43}],"term":"Pyrexia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":85},{"groupId":"EG001","numAffected":1,"numAtRisk":43}],"term":"Systemic Inflammatory Response Syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Liver Abscess"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":85},{"groupId":"EG001","numAffected":2,"numAtRisk":43}],"term":"Sepsis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Upper Respiratory Tract Infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":85},{"groupId":"EG001","numAffected":1,"numAtRisk":43}],"term":"Urinary Tract Infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":85},{"groupId":"EG001","numAffected":1,"numAtRisk":43}],"term":"Septic Shock"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":85},{"groupId":"EG001","numAffected":1,"numAtRisk":43}],"term":"Facial Bones Fracture"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Blood Bilirubin Increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":85},{"groupId":"EG001","numAffected":1,"numAtRisk":43}],"term":"Blood Creatinine Increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":85},{"groupId":"EG001","numAffected":1,"numAtRisk":43}],"term":"Hyperkaliemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Hypoglycemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Hypophosphatasemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":85},{"groupId":"EG001","numAffected":1,"numAtRisk":43}],"term":"Dehydration"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Musculoskeletal Chest Pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":85},{"groupId":"EG001","numAffected":1,"numAtRisk":43}],"term":"Tumor pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Hallucinations, mixed"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Mental Status Changes"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":85},{"groupId":"EG001","numAffected":2,"numAtRisk":43}],"term":"Acute Kidney Injury"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":85},{"groupId":"EG001","numAffected":1,"numAtRisk":43}],"term":"Urinary Retention"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Dyspnea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":85},{"groupId":"EG001","numAffected":1,"numAtRisk":43}],"term":"Hemoptysis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":85},{"groupId":"EG001","numAffected":1,"numAtRisk":43}],"term":"Pulmonary Edema"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA version 21.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":85},{"groupId":"EG001","numAffected":0,"numAtRisk":43}],"term":"Embolism"}],"timeFrame":"After Administration of the first dose of study drug and through 30 days after the last dose of study drug. A median of 28 weeks per participant for the ripretinib arm, and a median of 10 weeks per participant for the placebo arm."}